oldid86941

Ranbaxy starts reorganising Terapia Cluj

India's Ranbaxy group has started reorganising the Terapia Cluj drug maker it acquired this spring in a deal worth 324 million dollars (around 270 million euros). The company has set a target of a 6.2% market share and sales topping 100 million dollars (around...